News - Global

Filter

Current filters:

Global

Popular Filters

73 to 97 of 306 results

Zealand and Lilly to work together on type 2 diabetes and obesity therapies

29-08-2013

Denmark's Zealand Pharma (Nasdaq OMX: ZEAL) has announced an exclusive peptide drug R&D collaboration…

DiabetesEli LillyGlobalPharmaceuticalResearchZealand Pharma

Growing diabetes market will attract superior disease control

29-08-2013

The expected rise in diabetes is encouraging pharma companies to race to launch type 2 diabetes drugs,…

DiabetesFinancialGlobalPharmaceutical

Aid group urges countries not to trade away health as TPP negotiations intensify

23-08-2013

The far-reaching Trans-Pacific Partnership Agreement (TPP) should be a force for improving health outcomes…

GenericsGlobalPatentsPharmaceuticalPricing

Radiopharmaceuticals market to hit a value of $7.9 billion by 2018

21-08-2013

The radiopharmaceuticals market has been forecast to exceed a value of $7.9 billion by 2018, driven by…

Cardio-vascularGlobalMarkets & MarketingNeurologicalOncologyPharmaceutical

Study of failed drug troglitazone could explain idiosyncratic drug toxicity

20-08-2013

Scientists have advanced the study of trapping reactive metabolites in a move they say could be significant…

GlobalPharmaceuticalResearchSankyoTroglitazone

Multiple sclerosis market could reach $18.3 billion in 2018

19-08-2013

The multiple sclerosis (MS) market is expected to peak at $18.3 billion in 2018, according to healthcare…

AubagioBiogen IdecFinancialGilenyaGlobalNovartisPharmaceuticalSanofiTecfidera

In wake of Tivicay approval, MSF asks, "when will people in developing countries have access?"

13-08-2013

As the US Food and Drug Administration approved the new HIV drug Tivicay (dolutegravir) late Monday (The…

Anti-viralsdolutegravirGlobalHealthcarePharmaceuticalPricingTivicayViiV Healthcare

Actavis gains global rights for antifungal agent albaconazole

06-08-2013

US generic drugs major Actavis (NYSE: ACT),which also has strong interests in women's health products,…

ActavisalbaconazoleGlobalLicensingPalau PharmaPharmaceuticalWomen's Health

GAVI Alliance gets reduced price offers from Pfizer and GSK

30-07-2013

The price that the GAVI Alliance, a public/private partnership, pays for lifesaving pneumococcal vaccines…

GlaxoSmithKlineGlobalPfizerPharmaceuticalPricingVaccines

Ligand enters global license deal for women's health product

23-07-2013

Ligand Pharmaceuticals (Nasdaq: LGND) announces the signing of a global license agreement with recently-formed…

Azure BiotechBiotechnologyGloballasofoxifeneLicensingLigand PharmaceuticalsPfizerPharmaceuticalWomen's Health

US FDA fast-tracks Elan's Alzheimer's drug candidate

18-07-2013

Ireland-based Elan Corp (NYSE: ELN) says that the US Food and Drug Administration has granted Fast Track…

ElanELND005GlobalMarkets & MarketingNeurologicalNorth AmericaPharmaceuticalRegulation

Accenture launches $200 million business service to deliver pharma R&D more efficiently

12-07-2013

Global consultancy Accenture (NYSE: ACN) is investing more than $200 million to deliver a business service…

GlobalPharmaceuticalResearch

B-MS' nivolumab to lead NSCLC market with sales of $1.75 billion by 2022, says GlobalData

08-07-2013

US pharma major Bristol-Myers Squibb's (NYSE: BMY) nivolumab will overtake proven blockbuster competitors…

Bristol-Myers SquibbGlobalMarkets & MarketingnivolumabOncologyPharmaceutical

EU falsified medicines directive: imported active substances need written confirmation to guarantee GMP standards

03-07-2013

From July 2, 2013, all active substances manufactured outside of the European Union and imported into…

EuropeGenericsGlobalPharmaceuticalProductionRegulation

Bioventus in-licenses exclusive rights to Pfizer's BMP portfolio

02-07-2013

USA-based orthopedic healing specialist Bioventus, a spin out from the UK's Smith & Nephew to an Essex…

Anti-Arthritics/RheumaticsBioventusGlobalhyaluronic acidLicensingPfizerPharmaceutical

Global asthma market to reach 159 million lifetime cases by 2022

16-06-2013

Over 300 million people suffer from asthma, which translates to a drug market worth over $15 billion.…

GlaxoSmithKlineGlobalMarkets & MarketingMerck & CoPharmaceuticalRespiratory and PulmonarySeretideSingulair

WTO TRIPS resolution excludes pharma from IP extension exemption for least-developed countries

12-06-2013

The Council for TRIPS (Trade-Related Aspects of Intellectual Property Rights) yesterday (June 11) adopted…

GlobalPatentsPharmaceutical

73 to 97 of 306 results

Back to top